Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Total Liabilities : $0.94 Mil (As of Nov. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Total Liabilities?

Cannabis Bioscience International Holdings's Total Liabilities for the quarter that ended in Nov. 2023 was $0.94 Mil.

Cannabis Bioscience International Holdings's quarterly Total Liabilities declined from Nov. 2011 ($36.90 Mil) to Nov. 2022 ($0.00 Mil) but then increased from Nov. 2022 ($0.00 Mil) to Nov. 2023 ($0.94 Mil).

Cannabis Bioscience International Holdings's annual Total Liabilities increased from May. 2009 ($12.75 Mil) to May. 2010 ($21.59 Mil) and increased from May. 2010 ($21.59 Mil) to May. 2011 ($27.97 Mil).

Cannabis Bioscience International Holdings Total Liabilities Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Total Liabilities Chart

Cannabis Bioscience International Holdings Annual Data

Trend

Dec06

Dec07

May09

May10

May11

Total Liabilities

0.05

0.03

12.75

21.59

27.97

Cannabis Bioscience International Holdings Semi-Annual Data
	Dec06	Jun07	Dec07	Jun08	May09	Nov09	May10	Nov10	May11	Nov11	Nov22	Nov23
Total Liabilities	Get a 7-Day Free Trial							26.38	27.97	36.90	-	0.94

Cannabis Bioscience International Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cannabis Bioscience International Holdings's Total Liabilities for the fiscal year that ended in May. 2011 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	27.459	+	(0.516	+	-0.00099999999999945
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	27.97

Total Liabilities	=	Total Assets (A: May. 2011 )	-	Total Equity (A: May. 2011 )
	=	93.043	-	65.069
	=	27.97

Cannabis Bioscience International Holdings's Total Liabilities for the quarter that ended in Nov. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.66	+	(0.283	+	0.00099999999999995
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.94

Total Liabilities	=	Total Assets (Q: Nov. 2023 )	-	Total Equity (Q: Nov. 2023 )
	=	0.102	-	-0.842
	=	0.94

Cannabis Bioscience International Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036

Website

https://www.cbih.net

Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.